GUARNERI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 471
EU - Europa 49
AF - Africa 3
SA - Sud America 1
Totale 524
Nazione #
US - Stati Uniti d'America 467
IT - Italia 36
CA - Canada 4
DE - Germania 4
FI - Finlandia 4
ZA - Sudafrica 3
RU - Federazione Russa 2
CL - Cile 1
CZ - Repubblica Ceca 1
ES - Italia 1
GB - Regno Unito 1
Totale 524
Città #
Fairfield 63
Santa Cruz 50
Woodbridge 31
Ashburn 28
Seattle 27
Buffalo 26
Houston 21
Cambridge 20
Des Moines 18
Wilmington 16
Padova 13
Ann Arbor 6
Sant'elena 5
Chicago 4
Clearwater 4
Helsinki 4
San Diego 4
Lake Forest 3
Las Vegas 3
Los Angeles 3
Milan 3
Muizenberg 3
Ottawa 3
Council Bluffs 2
Dallas 2
Formia 2
Lombard 2
New York 2
Saint Louis 2
Verona 2
Atri 1
Auburn 1
Büdelsdorf 1
Chandler 1
Crugers 1
De Forest 1
Fleming Island 1
Frankfurt am Main 1
Hamilton 1
Henderson 1
Jacksonville 1
Madrid 1
Miami 1
Naples 1
New Orleans 1
Provo 1
Saint Petersburg 1
San Francisco 1
San Jose 1
University Park 1
Totale 392
Nome #
Exceptional and Durable Responses to TDM-1 After Trastuzumab Failure for Breast Cancer Skin Metastases: Potential Implications of an Immunological Sanctuary, file e14fb26b-58e2-3de1-e053-1705fe0ac030 104
Immune characterization of breast cancer metastases: Prognostic implications, file e14fb26b-3df6-3de1-e053-1705fe0ac030 86
GD2 expression in breast cancer, file e14fb26b-4c1f-3de1-e053-1705fe0ac030 85
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial, file e14fb26d-c4bd-3de1-e053-1705fe0ac030 63
Professional burnout in European young oncologists: results of the European Society for Medical Oncology (ESMO) Young Oncologists Committee Burnout Survey, file e14fb26e-f198-3de1-e053-1705fe0ac030 43
De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2 weeks letrozole: results of the PerELISA neoadjuvant study, file e14fb26f-919f-3de1-e053-1705fe0ac030 40
Interaction of host immunity with HER2-targeted treatment and tumor heterogeneity in HER2-positive breast cancer, file e14fb26e-bb7e-3de1-e053-1705fe0ac030 35
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer, file e14fb26e-e91d-3de1-e053-1705fe0ac030 32
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study, file e14fb26f-87e9-3de1-e053-1705fe0ac030 32
Non-Small-Cell Lung Cancer: Real-World Cost Consequence Analysis, file e14fb26e-984f-3de1-e053-1705fe0ac030 6
Synchronous and Metachronous Breast and Ovarian Cancer: Experience From Two Large Cancer Center, file 3363d94b-f351-4b49-8ef3-256a8e248144 5
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome, file e14fb26e-11ee-3de1-e053-1705fe0ac030 5
null, file 1a50f9a1-dde6-4c2d-9e6f-bc1e66264ac2 4
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1, file 07bb9d52-c7ee-4928-888f-11f9c2ad1923 2
null, file e14fb26d-ae1a-3de1-e053-1705fe0ac030 2
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines, file e14fb26f-0b99-3de1-e053-1705fe0ac030 2
Combined Immunoscore for Prognostic Stratification of Early Stage Non-Small-Cell Lung Cancer, file 5d68ff05-e19f-4875-83df-d1827ca9f647 1
A comprehensive profiling of the immune microenvironment of breast cancer brain metastases, file d91f45a0-b006-4394-9176-fa781a6ab62b 1
Totale 548
Categoria #
all - tutte 1084
article - articoli 1084
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2168


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0000 00 00 0022
2019/202052 0030 00 910 11946
2020/2021110 2925 16 311 1140182
2021/2022224 421118 2921 823 11116224
2022/2023158 1196027 924 171 0000
Totale 548